Gilead's lenacapavir applications for HIV gain EMA validation
Gilead's lenacapavir gained approval in several nations
for treating the adult population with multi-drug resistant HIV in
conjunction with other ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.